[Taylor&Francis] Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis

lulw Post time 2022-11-25 03:34:35 | Show all posts |Read mode
Reward10points

journal£ºImmunopharmacology and Immunotoxicology

Authors£ºTong Liu; Duo Liu; Yao Jin; Mei Dong

Published date£º--

DOI£º10.1080/08923973.2022.2090956

Article link£ºhttp://dx.doi.org/10.1080/08923973.2022.2090956

Article Source£ºInforma UK Limited¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Report

Reply all1 Show all posts
Georgee Post time 2022-11-25 03:34:36 | Show all posts
Please adopt

08923973.2022.2090956.pdf

1.67 MB, Downloads: 0

Document validity period: 10 days
Reply

Use magic Report

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list